ClinicalTrials.Veeva

Menu

Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer

R

Radboud University Medical Center

Status

Completed

Conditions

Rectal Neoplasms
Neoplasm Recurrence, Local

Study type

Observational

Funder types

Other

Identifiers

NCT05475301
K20.256

Details and patient eligibility

About

Data on disease recurrence was collected for all primary rectal cancer patients diagnosed in the Netherlands over the first six months of 2015. Three-year cumulative incidence, risk factors, treatment and three-year OS of locally recurrent rectal cancer were determined.

Enrollment

1,431 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed stage I-III primary rectal carcinoma;
  • Diagnosed between January 1st and June 30th of 2015;
  • TME resection of primary rectal carcinoma.

Exclusion criteria

  • Neuroendocrine tumor morphology;

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems